The Conversation (0)
Cocrystal Pharma (OTCQB: COCP) a biotechnology company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and/or chronic viral diseases, provided an update on the reverse stock split regarding the trading symbol. As quoted in the press release: The reverse stock split will be effective with the opening of trading on the …
Cocrystal Pharma (OTCQB: COCP) a biotechnology company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and/or chronic viral diseases, provided an update on the reverse stock split regarding the trading symbol.
As quoted in the press release:
The reverse stock split will be effective with the opening of trading on the OTCQB Market on Wednesday, January 24, 2018 on a split-adjusted basis under the trading symbol “COCPD.” After 20 business days, the trading symbol will change back to “COCP.”
As previously announced, the 1-for-30 reverse stock split will automatically convert thirty current shares of Cocrystal’s common stock into one new share of common stock. No fractional shares will be issued in connection with the reverse stock split.